ConductScience.org, home

Paper14737178

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.

Steelman LS and 5 others. Leukemia, 2004. Cited by 578 papers, by iCite.

Cite this record

ConductScience Library. JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Papers, record 14737178. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14737178

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.
PubMed
Journal
Leukemia
PubMed
Year
2004
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
578
iCite
Relative citation ratio, by iCite
10.8
iCite
Revised in PubMed
2026-10-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Steelman LSL S
2Pohnert SCS C
3Shelton JGJ G
4Franklin RAR A
5Bertrand FEF E
6McCubrey JAJ A

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell CycleMajor topic
LeukemiaMajor topic
Signal TransductionMajor topic
Animals
Apoptosis
Fusion Proteins, bcr-abl
Humans
Protein Kinases
Receptors, Cytokine

Source PubMed

Download CSV of topics

References459

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13037531Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/3037531PubMed
210698713Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations: differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase.Biochem J2000https://conductscience.org/library/papers/10698713PubMed
310558995Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice.Science1999https://conductscience.org/library/papers/10558995PubMed
47697542Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal.Immunity1995https://conductscience.org/library/papers/7697542PubMed
512529653Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia.Leukemia2003https://conductscience.org/library/papers/12529653PubMed
612186863A role for protein phosphatase-2A in p38 mitogen-activated protein kinase-mediated regulation of the c-Jun NH(2)-terminal kinase pathway in human neutrophils.J Biol Chem2002https://conductscience.org/library/papers/12186863PubMed
78389691Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells.EMBO J1993https://conductscience.org/library/papers/8389691PubMed
810822371The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3' kinase.Oncogene2000https://conductscience.org/library/papers/10822371PubMed
912594806A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?Int J Cancer2003https://conductscience.org/library/papers/12594806PubMed
1010704678Complex karyotype and N-RAS point mutation in a case of acute megakaryoblastic leukemia (M7) following a myelodysplastic syndrome.Cancer Genet Cytogenet2000https://conductscience.org/library/papers/10704678PubMed
1110523635BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis.Mol Cell Biol1999https://conductscience.org/library/papers/10523635PubMed
129680354Characterization of the role of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit in the activation of JAK2 and STAT5.Blood1998https://conductscience.org/library/papers/9680354PubMed
137759531Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase.J Biol Chem1995https://conductscience.org/library/papers/7759531PubMed
1411516100Blocking protein geranylgeranylation is essential for lovastatin-induced apoptosis of human acute myeloid leukemia cells.Leukemia2001https://conductscience.org/library/papers/11516100PubMed
157651428RAS signalling is abnormal in a c-raf1 MEK1 double mutant.Mol Cell Biol1995https://conductscience.org/library/papers/7651428PubMed
1610888033PKC412--a protein kinase inhibitor with a broad therapeutic potential.Anticancer Drug Des2000https://conductscience.org/library/papers/10888033PubMed
1712458225Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization.J Biol Chem2003https://conductscience.org/library/papers/12458225PubMed
187657393Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.Int J Cancer1995https://conductscience.org/library/papers/7657393PubMed
1912476305Novel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.Oncogene2002https://conductscience.org/library/papers/12476305PubMed
2010196176Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase.J Biol Chem1999https://conductscience.org/library/papers/10196176PubMed

See all 459 referencesDownload CSV of references

Cited by309

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 578 citations.

PMIDTitleJournalYearIn PapersSource
42857533Perioperative care of patients with chronic myeloid leukemia on tyrosine kinase inhibitors.Front Oncol2026https://conductscience.org/library/papers/42857533PubMed
42504206Deciphering the Multi-Target Therapeutic Mechanisms of Traditional Chinese Medicine Against Alzheimer's Disease: A Network Pharmacology Perspective.Drug Des Devel Ther2026https://conductscience.org/library/papers/42504206PubMed
42065040Data Mining for Identification of Targets and Repurposed Drugs to Eliminate Persistent Chronic Myeloid Leukaemia Stem Cells: Targeting RAS/RAF Signalling.Oncol Res2026https://conductscience.org/library/papers/42065040PubMed
41977180A Novel CIP2A and BCL-XL Clinical Diagnostic Toolkit to Predict Disease Progression and Treatment-Free Remission in Chronic Myeloid Leukaemia.Int J Mol Sci2026https://conductscience.org/library/papers/41977180PubMed
41810235Current research on the HIF-2α-EPO-Hb axis in hypoxic environments: from molecular mechanisms to clinical.Front Med (Lausanne)2026https://conductscience.org/library/papers/41810235PubMed
41428228Computational screening of natural phenolic compounds as potential EGFR inhibitors against triple negative breast cancer.J Mol Model2025https://conductscience.org/library/papers/41428228PubMed
41114875Thymoquinone-conjugated liposomes improve cytotoxic and proapoptotic effects against hepatocellular cancer by altering the EGFR/ERK/MEK signaling axis.Discov Oncol2025https://conductscience.org/library/papers/41114875PubMed
40948582Synergistic HER2-scFv mediated immunotherapy with targeted gemcitabine delivery harnessing biomimetic composite nanoparticles for enhanced metastatic tumor therapy.Mater Today Bio2025https://conductscience.org/library/papers/40948582PubMed
40911615Gene expression profiling and pathway analysis in acute myeloid leukaemia-normal karyotype patients.PLoS One2025https://conductscience.org/library/papers/40911615PubMed
40075566Lycorine hydrochloride Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting TRIM22 and Inhibiting the JAK2/STAT3 and Erk Pathways.Cancers (Basel)2025https://conductscience.org/library/papers/40075566PubMed
39980929Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells.Front Public Health2025https://conductscience.org/library/papers/39980929PubMed
39739720Combination of triciribine and p38 MAPK inhibitor PD169316 enhances the differentiation effect on myeloid leukemia cells.PLoS One2024https://conductscience.org/library/papers/39739720PubMed
39567540Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting.Nat Commun2024https://conductscience.org/library/papers/39567540PubMed
39510293Lessons learned from 20 years of preclinical testing in pediatric cancers.Pharmacol Ther2024https://conductscience.org/library/papers/39510293PubMed
39327314Identification of a novel cryptic variant chromosomal rearrangement involving 9q34, 22q11.2, and 5q22 resulting in ins(9;22) and t(5;22) in chronic myeloid leukemia: a case report.Ann Hematol2024https://conductscience.org/library/papers/39327314PubMed
39258309NaV1.1 contributes to the cell cycle of human mesenchymal stem cells by regulating AKT and CDK2.J Cell Sci2024https://conductscience.org/library/papers/39258309PubMed
39217250Reversible control of kinase signaling through chemical-induced dephosphorylation.Commun Biol2024https://conductscience.org/library/papers/39217250PubMed
39138146Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39138146PubMed
38947742Exploiting the potential of the ubiquitin-proteasome system in overcoming tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Genes Dis2024https://conductscience.org/library/papers/38947742PubMed
38743735Identification of triciribine as a novel myeloid cell differentiation inducer.PLoS One2024https://conductscience.org/library/papers/38743735PubMed

See all 309 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
MAP2K75609PubTator's text mininghttps://conductscience.org/library/genes/5609NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
ZHX222882PubTator's text mininghttps://conductscience.org/library/genes/22882NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14737178

GET https://conductscience.org/api/papers/v1/14737178/references?page=2